Reference

Worked example: Alder Ridge Health

Part of the KPI Architecture skill · loaded on demand from SKILL.md

Read this when you want to see a complete, end-to-end output: strategy map, scorecard, measure-definition sheets, value-realisation ledger with stage gates, the P&L reconciliation, and the review cadence, with numbers that tie.

Contents

  1. Client situation and inputs received
  2. Financial anchor and value gap
  3. Strategy map
  4. Linkage hypotheses (the arrows, written out)
  5. Scorecard: measures, lead/lag, owners, baselines, targets
  6. Measure-definition sheets (three shown in full)
  7. Value-realisation ledger at month 9
  8. Reconciliation: ledger to P&L
  9. Review cadence and what happened at the month-9 review
  10. What the partner challenged before it went to the client

1. Client situation and inputs received

Alder Ridge Health is a non-profit regional health system serving a mid-sized metropolitan area and the surrounding counties in the US Southeast. Five acute hospitals (one 520-bed tertiary hub and four community hospitals of 180 to 320 beds, 1,640 licensed beds in total), 38 outpatient clinics, an employed medical group of about 640 physicians and advanced practice providers, and roughly 14,500 employees. Total operating revenue $2,400M; 82,000 inpatient admissions, 128,000 adjusted admissions and 700,000 adjusted patient days a year. Operating EBITDA (operating income before depreciation, amortisation and interest) is $144.0M, a 6.0 percent margin; after $112M of depreciation and interest the operating margin is 1.3 percent, and it has been below 2 percent for two years. The bond rating agency moved the outlook to negative last year. The board's finance committee has set a target of 8.5 percent operating EBITDA margin by the end of FY3, the level it judges necessary to fund the capital plan and hold the rating.

The executive team named in this example:

RoleNameShort form used in tables
Chief executiveMargaret OkaforCEO
Chief financial officerDaniel ReissCFO
Chief operating officerPriya VenkataramanCOO
Chief medical officerDr Thomas LindqvistCMO
Chief nursing officerAngela TorresCNO
President, employed medical groupDr Samuel BoatengPresident, Medical Group
Chief human resources officerLaura BennettCHRO
Chief information officerRachel HuangCIO
Chief quality officerDr Nadia RahmanCQO
Vice president, revenue cycleKaren WhitfieldVP Revenue Cycle
Vice president, supply chain and purchased servicesMarcus DelgadoVP Supply Chain
Chief transformation officerElena SorensenCTO

Inputs received from upstream skills:

  • From strategic-choice: the chosen position is "the reliable system of care close to home": the same outcomes as the academic centre in the city, delivered in the region, with a bed or an appointment available when it is needed. It is delivered through clinical standardisation on the twelve highest-volume conditions, patient flow, a stable employed nursing workforce, ambulatory access, and revenue integrity.
  • From execution-planning: six chartered initiatives with sponsors and owners, a transformation office (TO) of five people led by the chief transformation officer reporting to the CEO, and a 90-day plan already under way.
  • From value-driver-modeling: the baseline P&L and the driver tree that sizes each initiative.

What was missing and assumed: no history of initiative tracking exists, so all baselines are set at FY0 actuals; the finance function has agreed to provide a controller two days a week to the TO. The four-line financial anchor uses the hospital equivalents of the standard lines: total operating revenue, labour cost (salaries, wages, benefits and contract labour), non-labour operating expense (supplies, drugs, purchased services and other), and operating EBITDA. The reconstruction from the management accounts is labelled as such and signed by the CFO.

2. Financial anchor and value gap

LineFY0 actualFY3 targetChange
Total operating revenue$2,400.0M$2,640.0M+$240.0M (3.2 percent CAGR)
Labour cost (salaries, wages, benefits, contract labour)$1,344.0M (56.0 percent of revenue)$1,425.6M (54.0 percent)+$81.6M
Non-labour operating expense (supplies, drugs, purchased services, other)$912.0M (38.0 percent)$990.0M (37.5 percent)+$78.0M
Operating EBITDA$144.0M (6.0 percent)$224.4M (8.5 percent)+$80.4M

Operating EBITDA bridge FY0 to FY3, run-rate basis:

Component$M
FY0 operating EBITDA144.0
Initiative run-rate value (six boulders plus sand, see ledger)+106.4
Organic growth contribution ($160M of the $240M incremental revenue is payer rate and demographic growth independent of the programme, at 20 percent contribution after variable cost)+32.0
Wage and non-labour inflation on the base, three years, net of contracted payer rate increases-58.0
FY3 operating EBITDA224.4

So the initiative portfolio must deliver $106.4M of run-rate value for the plan to land at $224.4M, and the value gap the board cares about is $80.4M. The remaining $80M of incremental revenue is initiative-driven (retained admissions from freed capacity, ambulatory growth) and sits inside the run-rate figure. Coverage of identified initiatives over the required value is examined in section 7.

Year-1 plan: revenue $2,470M, initiative value landing in the FY1 P&L $38.0M, one-off implementation costs $9.5M, headwinds net of organic contribution $6.5M. FY1 operating EBITDA plan: 144.0 + 38.0 - 9.5 - 6.5 = $166.0M, a 6.7 percent margin.

3. Strategy map

Read bottom to top. Objectives are outcomes, not activities. Arrows are listed in section 4.

Financial

  • F1 Reach 8.5 percent operating EBITDA margin ($224.4M) by FY3
  • F2 Reduce cost per unit of care: labour cost per adjusted patient day to $1,840 and supply and drug cost per adjusted admission to $3,510 (productivity: workforce, flow, standardisation)
  • F3 Grow net revenue to $2,640M (growth: access, retained capacity, quality-linked payments)
  • F4 Collect what is earned: final denial write-offs from 1.9 to 1.0 percent of net revenue (productivity: revenue integrity)

Customer: patients, families, referring clinicians and payers (value proposition: the reliable system of care close to home)

  • C1 Patients get a bed or an appointment when they need one, and referrals stay in the system
  • C2 Patients recover without avoidable harm or unplanned return
  • C3 Patients and families would recommend the hospital

Internal process

  • I1 Every eligible patient is treated on the agreed care pathway (clinical standardisation, twelve conditions)
  • I2 Patients move through the hospital without waiting on the system (flow)
  • I3 Every shift is staffed to plan with the system's own workforce
  • I4 Ambulatory capacity is filled and new patients are seen within a week
  • I5 Every encounter is documented, coded and billed correctly the first time

Learning and growth

  • L1 The nursing workforce is stable and experienced (human capital)
  • L2 Physicians lead pathway and service-line performance, with incentives aligned to system outcomes (organisation capital)
  • L3 Clinical and operational data is timely and trusted: real-time bed status, central scheduling, claim edits in the EHR (information capital)

Strategic themes (the vertical slices through the map): Clinical reliability (L2, I1, C2, F2), Flow and capacity (L3, I2, C1, F3), Workforce stability (L1, I3, C3, F2), Access and revenue integrity (L3, I4, I5, C1, F3, F4).

4. Linkage hypotheses (the arrows, written out)

Each arrow is an if-then statement with the lead and lag measure pair and an expected lag time. These are the hypotheses the quarterly review tests.

ArrowHypothesisLead measure (tail)Lag measure (head)Expected lag
L1 to I3If first-year RN turnover falls from 31 to 18 percent, contract-labour share of nursing hours falls from 11.0 to 4.0 percentFirst-year RN turnover, percentContract-labour share of nursing hours, percent2 quarters
L2 to I1If all 12 pathways have a physician-nurse dyad in post and an order set live in the EHR, order-set adherence rises from 54 to 85 percentPathways with dyad in post and order set live, of 12Pathway order-set adherence, percent1 quarter
L3 to I2If the real-time bed board and discharge-readiness flag are live in all five hospitals, discharges before noon rise from 18 to 40 percentHospitals live on real-time bed board, of 5Discharges before noon, percent1 quarter
L3 to I4If central scheduling with standard templates covers all 38 clinics, third-next-available appointment in primary care falls from 21 to 7 daysClinics on central scheduling, of 38Third-next-available appointment, days1 quarter
L3 to I5If claim-edit rules and the documentation-query worklist are live in the EHR, clean-claim rate rises from 84 to 95 percentClaim edits and query worklist live, yes/noClean-claim rate, percent1 quarter
I1 to C2If adherence reaches 85 percent, risk-adjusted 30-day readmission falls from 15.2 to 13.0 percentPathway order-set adherence30-day readmission, risk-adjusted, percent2 quarters
I1 to F2If adherence reaches 85 percent, supply and drug cost per adjusted admission falls 6.4 percent through preference-item and formulary standardisationPathway order-set adherenceSupply and drug cost per adjusted admission, $2 quarters
I2 to C1If observed-to-expected length of stay falls from 1.12 to 1.00, ED boarding hours fall from 92,000 to 40,000 a yearObserved-to-expected length of stayED boarding hours, admitted patients1 quarter
I3 to F2If contract-labour share falls to 4.0 percent, labour cost per adjusted patient day falls from $1,920 to $1,840Contract-labour share of nursing hoursLabour cost per adjusted patient day, $1 quarter
I3 to C3If shifts staffed to plan rise from 82 to 95 percent, the HCAHPS "would recommend" top-box score rises from 68 to 74 percentShifts staffed to plan, percentHCAHPS recommend, top-box percent2 quarters
I4 to C1If third-next-available falls to 7 days and slot utilisation rises from 78 to 90 percent, referral keepage rises from 61 to 70 percentThird-next-available appointment, daysReferral keepage, percent2 quarters
I5 to F4If clean-claim rate reaches 95 percent, initial denials fall from 11.8 to 7.0 percent and final denial write-offs fall from 1.9 to 1.0 percent of net revenueClean-claim rateFinal denial write-offs, percent of net revenue2 quarters
C1 to F3If ED boarding hours fall to 40,000 and keepage reaches 70 percent, retained admissions and ambulatory visits take net revenue to $2,640MED boarding hours; referral keepageNet revenue, $M3 to 4 quarters
C2 to F3If readmission falls to 13.0 percent and hospital-acquired conditions to 2.4 per 1,000 patient days, the quality-linked payments in commercial and government contracts (about $9M a year at risk) are earned rather than forfeited30-day readmission; hospital-acquired conditionsQuality-linked contract payments earned, $M (component of F3)4 quarters
C3 to F3If recommend reaches 74 percent, inpatient share in the primary service area holds at or above 38.5 percent while capacity growsHCAHPS recommendInpatient market share, primary service area, percent (component of F3)4 quarters

Linkage test applied: every objective has at least one inbound and one outbound arrow except the L-row (no inbound) and F1 (no outbound; F2, F3 and F4 feed F1 by arithmetic). No orphan objectives. Total arrows: 15. The first draft had 28; the executive team cut the ones nobody would defend under questioning, including "engagement drives everything" and three arrows from data quality to financial outcomes with no process in between.

5. Scorecard: measures, lead/lag, owners, baselines, targets

Twenty measures. Frequency is the review frequency, not the data-capture frequency.

RefObjectiveMeasureTypeOwnerBaseline FY0FY1 targetFY3 targetFreq
F1MarginOperating EBITDA / total operating revenue, percentLagCFO6.06.78.5Monthly
F2Cost per unit of careLabour cost per adjusted patient day, $LagCOO1,9201,8901,840Monthly
F2Cost per unit of careSupply and drug cost per adjusted admission, $LagVP Supply Chain3,7503,6503,510Monthly
F3RevenueNet revenue, $MLagCEO2,4002,4702,640Monthly
F4Revenue integrityFinal denial write-offs, percent of net revenueLagCFO1.91.51.0Monthly
C1Access and retentionED boarding hours, admitted patients, annualisedLagCOO92,00065,00040,000Monthly
C1Access and retentionReferral keepage, percent of in-system referrals scheduled in-systemLagPresident, Medical Group616570Quarterly
C2Outcomes30-day all-cause readmission, risk-adjusted, percentLagCMO15.214.213.0Monthly
C2OutcomesHospital-acquired conditions per 1,000 patient daysHealthCQO3.12.82.4Monthly
C3ExperienceHCAHPS "would recommend", top-box percentLagCNO687174Quarterly
I1PathwaysPathway order-set adherence, percent of eligible encountersLeadCMO547885Weekly
I2FlowDischarges before noon, percentLeadCOO183240Weekly
I2FlowObserved-to-expected length of stayLagCOO1.121.051.00Weekly
I3StaffingContract-labour share of nursing hours, percentLeadCNO11.07.04.0Weekly
I3StaffingShifts staffed to plan, percent (pairing for contract-labour reduction)HealthCNO829095Weekly
I4Ambulatory accessThird-next-available appointment, primary care, daysLeadPresident, Medical Group21127Weekly
I5Revenue integrityClean-claim rate, percentLeadVP Revenue Cycle849295Weekly
L1WorkforceFirst-year RN turnover, percentLeadCHRO312218Monthly
L2Physician leadershipPathways with dyad in post and order set live, of 12LeadCMO31212Monthly to 12, then retire
L3DataHospitals live on real-time bed board with discharge-readiness flag, of 5LeadCIO155Monthly to 5, then retire

Measures considered and rejected: "nurse education hours delivered" (activity, replaced by first-year turnover and the staffing measure it is supposed to drive); "number of order sets built" (kept only as an initiative milestone, not a scorecard measure); "patient portal enrolments" (not causal to anything on the map in this strategy period); "average daily census" (ambiguous: it rises when flow worsens as well as when demand grows, so it cannot be read without the flow measures beside it); "employee engagement score" (kept in the HR dashboard; first-year turnover is the measure on the arrow).

Two temporary measures carry retirement rules. "Pathways with dyad in post and order set live" is retired when it reaches 12 of 12 and replaced by "pathways with adherence below 75 percent for two consecutive months", which is the ongoing capability signal. "Hospitals live on real-time bed board" is retired at 5 of 5; the arrow's lag measure, discharges before noon, carries on.

6. Measure-definition sheets (three shown in full)

Measure: Pathway order-set adherence, percent (I1, lead)

FieldDefinition
FormulaInpatient encounters with a principal diagnosis in one of the 12 pathway conditions (diagnosis-code list versioned by the CMO's office) where the pathway order set was used within the pathway's timing window and at least 80 percent of the required bundle elements were completed, divided by all encounters with a qualifying principal diagnosis discharged in the period. Excludes patients under 18, transfers in more than 24 hours after admission elsewhere, and patients placed on comfort care within 24 hours of admission.
Data sourceEHR encounter table joined to the order-set usage log and the pathway element table by encounter ID. Principal diagnosis is taken from the final coded record, so the measure finalises about ten days after month end; the weekly figure uses provisional coding and is labelled as such. Diagnosis-code lists are versioned; use the version in force on the discharge date.
FrequencyCalculated daily on provisional coding; reviewed weekly at the TO meeting; reported monthly on final coding.
OwnerCMO (accountable). Data steward: clinical informatics analyst.
Baseline54.2 percent, FY0 full year, 31,400 qualifying encounters.
Target78 percent by end FY1; 85 percent by end FY2 and sustained.
Related measure (pairing)30-day readmission (C2) and supply and drug cost per adjusted admission (F2). Adherence rising while neither moves indicates order sets being opened and edited rather than followed; the share of order sets opened with more than 40 percent of elements removed is reported alongside the measure.
Value linkFeeds ledger initiative V2. Value is computed as (FY0 supply and drug cost per case for the condition minus actual cost per case) times cases in the period, at constant FY0 unit prices.
Double-count ruleV2 is measured on units per case at constant FY0 unit prices. Unit-price changes from contracting are attributed to the supply-chain sand initiatives, which are measured at constant volume and mix. The same rule is written in those initiatives' sheets.
Known limitationsThe 12 conditions cover about 38 percent of discharges and 55 percent of supply and drug spend; conditions outside the list are not measured. Coding finalisation lags the month end. Reported with the exclusion count.
Change controlAny change to the formula, the bundle elements or the diagnosis-code lists requires CMO and CFO sign-off and a restated baseline.

Measure: Contract-labour share of nursing hours, percent (I3, lead)

FieldDefinition
FormulaHours worked by agency and travel registered nurses, licensed practical nurses and nursing assistants on inpatient and emergency units, divided by all worked nursing hours on those units, in the period. Internal float pool and per-diem employees count as the system's own staff. Overtime hours count as employed hours.
Data sourceTimekeeping system, worked hours by job code and employer code, joined to the agency invoice file by cost centre and pay period. Both are versioned by pay period; use the pay period in which the hours were worked.
FrequencyCalculated per pay period (fortnightly); reviewed weekly at the TO meeting; reported monthly.
OwnerCNO. Data steward: nursing finance analyst.
Baseline11.0 percent, FY0 ($869,000 of 7.9M worked nursing hours).
Target7.0 percent end FY1; 4.0 percent end FY3.
Related measure (pairing)Shifts staffed to plan (I3 health) and hospital-acquired conditions (C2 health). A falling contract share while shifts staffed to plan also falls means the share is being cut by running units short, which the CNO must approve unit by unit.
Value linkFeeds ledger initiative V1. Value is computed as (baseline share minus actual share) times worked nursing hours in the period times the contract premium ($52 per hour in FY0: average agency invoiced rate less average employed fully loaded rate, re-measured quarterly).
Double-count ruleV1 counts the premium on contract hours only. V3 (flow) counts hours removed from the roster by flex-unit closure at employed rates. A contract hour that V3 removes is counted in V3 at the employed rate and in V1 at the premium only; nothing is counted twice. Written in both sheets.
Known limitationsAgency hours in respiratory therapy, imaging and laboratory are outside the measure and tracked in sand. The premium varies by specialty (critical care highest); reported with the specialty mix.
Change controlAny change to the formula or the premium method requires CFO sign-off and a restated baseline.

Measure: Realised initiative value, $M operating EBITDA (ledger, tier 3)

FieldDefinition
FormulaFor each initiative at L4 or L5: the difference between actual P&L line(s) in the period and the agreed baseline for those lines, adjusted for the volume and payer-mix effects specified in the business case, summed across initiatives. Reported in-year (what has hit this fiscal year's P&L) and run-rate (annualised effect of changes already made).
Data sourceManagement accounts; initiative baseline sheets; adjustments computed by the TO controller and signed by the hospital division controller or the system controller.
FrequencyMonthly, at the value review.
OwnerCFO (accountable); TO controller (calculates).
BaselineDefined per initiative at L2 and frozen. Baselines are not re-set unless the CFO approves a restatement, which is logged.
RulesValue is reported as realised at L5 only. L4 value is shown as "assessed, not yet realised". Value observed in the P&L from initiatives still at L3 is shown as "early value, unvalidated". Forecast value for L1 and L2 is shown separately and never added to realised value in any headline number. One-off costs are shown on a separate line, never netted silently.

7. Value-realisation ledger at month 9

Snapshot at the end of month 9 of FY1. All figures $M operating EBITDA. "Run-rate" is the annualised value once fully implemented; "FY1 in-year" is what the phasing plan expected to land in the FY1 P&L; "YTD in P&L" is finance-assessed value against the frozen baseline for initiatives at L3 and above. Only the L5 portion is reported as "realised" to the board; the stage split is shown below the table.

IDInitiativeOwnerFinance validatorStageRun-rate targetFY1 in-year targetYTD in P&L (M9)FY1 forecastVariance vs FY1 targetNext gate
V1Nursing workforce stabilisation (contract labour to 4 percent)CNOHospital division controllerL422.09.06.89.6+0.6L5 review, month 11
V2Clinical pathways and supply standardisation, 12 conditionsCMOHospital division controllerL315.54.52.13.6-0.9L4 planned month 14
V3Patient flow and length of stayCOOSystem controllerL318.06.03.45.2-0.8L4 planned month 13
V4Ambulatory access and growthPresident, Medical GroupHospital division controllerL210.01.50.00.9-0.6L3 gate month 10
V5Revenue integrity (denials, documentation)VP Revenue CycleSystem controllerL313.54.02.33.8-0.2L4 planned month 15
V6Purchased-services and non-clinical contract renegotiationVP Supply ChainSystem controllerL59.46.33.96.30.0Closed; sustain check month 12
SSand: 26 initiatives each under $1.0MVariousTO controllerL2 to L518.06.74.36.4-0.3Rolling
Total106.438.022.835.8-2.2

Stage split of the $22.8M year-to-date in P&L: L5 realised $6.5M (V6 3.9, sand 2.6); L4 assessed, awaiting finance sign-off $7.7M (V1 6.8, sand 0.9); L3 early value from initiatives still in execution $8.6M (V2 2.1, V3 3.4, V5 2.3, sand 0.8). The board report headline is "$6.5M realised", with the other two as separate bars.

Pipeline and coverage:

StageInitiativesRun-rate value $M
L5 Realised1 boulder, 7 sand14.0
L4 Implemented, under finance assessment1 boulder, 5 sand25.4
L3 In execution3 boulders, 8 sand53.1
L2 Business case approved1 boulder, 6 sand13.9
Subtotal L2 and above32106.4
L1 Validated, business case in preparation1146.0
L0 Ideas logged, unsized or rough44about 30

Stage subtotals tie to the run-rate column: V6 (9.4) plus 7 sand (4.6) = 14.0; V1 (22.0) plus 5 sand (3.4) = 25.4; V2, V3 and V5 (47.0) plus 8 sand (6.1) = 53.1; V4 (10.0) plus 6 sand (3.9) = 13.9. Sand total 4.6 + 3.4 + 6.1 + 3.9 = 18.0.

Coverage: L2-and-above value of $106.4M against required $106.4M run-rate is 100 percent, and against the $80.4M board gap is 132 percent. The public McKinsey rule of thumb is that value estimates attrite by around 70 percent from L1 to L5, so a pipeline of only 1.0x at L2 and 1.4x including L1 is thin. The TO's action from this review: move at least $25M of L1 value to L2 by month 12, and run a second idea-generation wave in the community hospitals and the clinics to refill L0.

Business-case logic for each boulder (so the run-rate numbers can be audited):

  • V1: Contract-labour share of 7.9M worked nursing hours falls from 11.0 to 4.0 percent, 7.0 points, 553,000 hours at a $52 premium: $28.8M. Less $6.8M of retention investment (nurse residency programme, float-pool differentials, 20 float FTEs): $22.0M.
  • V2: Supply and drug spend on the 12 pathway conditions is $264M (55 percent of $480M). A 7 percent reduction in units per case from preference-item and formulary standardisation is $18.5M, less $3.0M of dyad time, pharmacy and analytics staff: $15.5M.
  • V3: Observed-to-expected length of stay from 1.12 to 1.00 on 380,000 inpatient days frees 380,000 x (1 - 1.00 / 1.12) = 40,700 bed-days. 55 percent are backfilled with retained admissions (22,400 bed-days at an average stay of 4.6 days is 4,870 admissions at $2,800 contribution): $13.6M. The other 45 percent close flex units (18,300 bed-days at $360 variable staffing cost): $6.6M. Total $20.2M, less $2.2M of care-management and discharge-lounge staff: $18.0M. Note: the backfill share was 65 percent in the charter and was tightened to 55 percent at L2 after the payer-mix review; the difference sits in the L2 log.
  • V4: Slot utilisation from 78 to 90 percent on 1.05M template slots is 126,000 additional visits at $160 net revenue and 40 percent contribution: $8.1M. Keepage from 61 to 70 percent on 46,000 specialty referrals retains 4,140 referrals at $1,300 downstream contribution: $5.4M. Total $13.5M, less $3.5M of advanced practice providers and the central scheduling centre: $10.0M.
  • V5: Final denial write-offs from 1.9 to 1.0 percent of $2,400M net revenue is $21.6M. A 75 percent realisation factor (some denials are payer behaviour, not documentation) gives $16.2M, less $2.7M of documentation specialists and denials analysts: $13.5M.
  • V6: Renegotiated environmental services, linen, food service, IT maintenance and insurance contracts, $9.4M, landed in month 5 and validated in the management accounts for three consecutive months by month 8. FY1 in-year value is eight months, $6.3M.

8. Reconciliation: ledger to P&L

The month-9 value review reconciled the ledger to the management accounts:

LinePlan FY1Forecast FY1 (M9)Comment
FY0 operating EBITDA144.0144.0Frozen baseline
Initiative value in-year+38.0+35.8Per ledger; V2, V3 and V4 behind, V1 ahead
One-off implementation costs-9.5-10.1Nurse residency and float-pool start-up 3.6, EHR build (order sets, bed board, claim edits) 2.4, documentation and denials staffing ahead of value 1.5, scheduling centre fit-out 1.4, consulting support 1.2, including 0.6 of unplanned EHR contractor time on the bed board
Headwinds net of organic contribution (contract-labour rate inflation on remaining hours, specialty drug inflation, payer-mix shift toward government payers, less rate and volume growth)-6.5-6.3Independent of the programme; tracked so the programme is neither blamed nor credited
FY1 operating EBITDA166.0163.46.7 percent plan; 6.6 percent forecast on $2,462M revenue

Check: 144.0 + 35.8 - 10.1 - 6.3 = 163.4. The management-accounts forecast produced by FP&A independently of the TO was $163.9M; the $0.5M difference was traced to the labour budget of one community hospital, which still holds the cost of a flex unit that V3 closes in month 11, and was logged.

9. Review cadence and what happened at the month-9 review

ForumFrequencyAttendeesInputsDecisions taken
TO initiative reviewWeekly, Tuesday 07:30, 60 minutesCTO, TO team, initiative owners in rotationMilestone status, lead measures, blockersStage moves L1 to L4; unblocking; owner changes
Value reviewMonthly, week 2 after closeCFO, system controller, CTO, TO controller, owners of initiatives at L4 or L5Ledger, management accounts, baseline adjustmentsL5 sign-off; baseline restatements; forecast changes
Scorecard and strategy reviewQuarterlyCEO, executive team, CTOScorecard, linkage-hypothesis status, ledger summaryConfirm or revise hypotheses; add or retire measures; reallocate resources
Board value reportQuarterly, to the finance committee and the quality committee jointlyBoardOne-page: realised, assessed, forecast, pipeline, coverage; scorecard headlinesInvestment approvals; target confirmation
Strategy map refreshAnnual, or on a strategic-choice changeCEO, executive teamFull map and scorecardRebuild map if the strategy changed; otherwise reconfirm

At the month-9 scorecard review the hypothesis test produced two findings:

  1. Workforce stability is working as mapped. First-year RN turnover fell from 31 to 23 percent (year-end target 22); contract-labour share fell from 11.0 to 6.4 percent, already past the year-end target of 7.0; labour cost per adjusted patient day is down $24 at $1,896 against a one-quarter expectation of about $20 at this point. Shifts staffed to plan rose from 82 to 89 percent, so the reduction is real, not units running short. V1 is on course to exceed its FY1 in-year target.
  2. Clinical pathways are behind, and the map located the cause. Adherence rose from 54 to 66 percent (month-9 plan 72), and supply and drug cost per adjusted admission fell from $3,750 to $3,712 (plan $3,685). The lead measure upstream, pathways with dyad in post and order set live, reached 7 of 12 against a plan of 11: all twelve dyads are in post, but order sets are live for only seven conditions because the EHR build team was diverted to the bed board for V3. The lead did not move, so this is execution, not a failed hypothesis; readmission has in fact moved from 15.2 to 14.7 percent because the seven live pathways include the three highest-readmission conditions. The action was to move two EHR analysts from V4's central-scheduling build to the order-set build for ten weeks, accept a one-quarter delay to V4's L3 gate, and re-phase V2 in-year value from 4.5 to 3.6. The run-rate target of $15.5M was left unchanged.

10. What the partner challenged before it went to the client

  • "Your headline said 'value delivered $22.8M'. It is $6.5M realised at L5, $7.7M under assessment at L4, and $8.6M early value from initiatives still at L3. Only the first is delivered. Rewrite the headline with the stage split." Done; the board page now shows realised, assessed, early and forecast as separate bars.
  • "V1 and V3 both take labour hours out of the same units. Show me the double-count rule in the definition sheets." Added to both sheets (section 6): V1 counts the contract premium only, V3 counts hours removed at employed rates.
  • "Readmission is your health measure for length of stay. If it is on a different page from observed-to-expected LOS, someone will cut stay and nobody will see the return visits until the quarter is over." The two measures now sit on the same row of the weekly flow page, and the V3 charter carries a response protocol: pause the flex-unit closures in any hospital where risk-adjusted readmission rises above 15.5 percent for two consecutive months.
  • "The coverage line says 100 percent. Given the attrition data, that is a warning, not a comfort. Say so." Rewritten as in section 7.
  • "Retire 'pathways with dyad and order set' when it hits 12, and the bed-board count when it hits 5. A scorecard measure that reads complete forever is dead weight." Retirement rules added.